tocilizumab

Tocilizumab Has Limited Clinical Utility for COVID19 in Two Multiethnic Community Hospitals

K. Cervellione, G. Dadi, N. Hameedi, M. Pignanelli, B. Kuriakose, V. Zafonte, T. Ullah, J. Robitsek, G. Pena Fatule, H. Patel, D. M. Wisa, K. Gafoor, M. Walczyszyn, J. Shakil, F. Bagheri, A. Solinas, R. Mendelson

Development of Bloodstream Infection After Tocilizumab Treatment for SARS-CoV-2 Cytokine Storm

Zafonte, Veronica; Pena, Grace Martinez; Patel, Harsh; Shinn, Grace; Jagata, Ravali; Cervellione, Kelly; Bosco, Michael; Wisa, David; Walczyszyn, Maciej; Shakil, Javeria; Patel, Mahendra; Bagheri, Farshad; Gafoor, Khalid